SSKN vs. MBOT, NXGL, GCTK, PETV, BTCY, PSTV, NURO, OSA, MHUA, and INBS
Should you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include Microbot Medical (MBOT), NEXGEL (NXGL), GlucoTrack (GCTK), PetVivo (PETV), Biotricity (BTCY), Plus Therapeutics (PSTV), NeuroMetrix (NURO), ProSomnus (OSA), Meihua International Medical Technologies (MHUA), and Intelligent Bio Solutions (INBS). These companies are all part of the "surgical & medical instruments" industry.
STRATA Skin Sciences (NASDAQ:SSKN) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking and institutional ownership.
Microbot Medical received 123 more outperform votes than STRATA Skin Sciences when rated by MarketBeat users. Likewise, 70.61% of users gave Microbot Medical an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.
STRATA Skin Sciences has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500.
Microbot Medical has lower revenue, but higher earnings than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.
32.4% of STRATA Skin Sciences shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 40.4% of STRATA Skin Sciences shares are held by company insiders. Comparatively, 10.6% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
In the previous week, STRATA Skin Sciences had 11 more articles in the media than Microbot Medical. MarketBeat recorded 14 mentions for STRATA Skin Sciences and 3 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.56 beat STRATA Skin Sciences' score of 0.04 indicating that Microbot Medical is being referred to more favorably in the news media.
Microbot Medical has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -34.92%. STRATA Skin Sciences' return on equity of -65.76% beat Microbot Medical's return on equity.
STRATA Skin Sciences currently has a consensus price target of $3.80, indicating a potential upside of 874.36%. Microbot Medical has a consensus price target of $7.00, indicating a potential upside of 629.17%. Given STRATA Skin Sciences' higher possible upside, research analysts clearly believe STRATA Skin Sciences is more favorable than Microbot Medical.
Summary
STRATA Skin Sciences and Microbot Medical tied by winning 8 of the 16 factors compared between the two stocks.
Get STRATA Skin Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
STRATA Skin Sciences Competitors List
Related Companies and Tools
